OYST - Oyster Point Pharma Inc. (OYST) CEO Jeffrey Nau on Q4 2020 Results - Earnings Call Transcript
Oyster Point Pharma, Inc. (OYST) Q4 2020 Earnings Conference Call February 18, 2021, 04:30 PM ET Company Participants Daniel Lochner - CFO Jeffrey Nau - President and CEO John Snisarenko - Chief Commercial Officer Conference Call Participants Anupam Rama - JPMorgan Tara Bancroft - Piper Sandler Ken Cacciatore - Cowen & Co. Patrick Dolezal - LifeSci Capital Presentation Operator Good evening and welcome to Oyster Point Pharma’s Fourth Quarter 2020 Earnings Conference Call. My name is Josh, and I’ll be your operator today. After the company’s formal remarks, there will be question-and-answer session. At this time, I would like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma’s, Chief Financial Officer. Sir, please go ahead. Daniel Lochner Good evening, everyone, and welcome to the Oyster Point Pharma’s fourth quarter earnings conference call for the three months ending December 31, 2020. This evening, we issued a press release
For further details see:
Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2020 Results - Earnings Call Transcript